Evaluation of Serum Vitamin D Concentration and Blood Eosinophil and Basophil Counts in Patients With Vitiligo: A Cross-sectional Study From Rafsanjan and Zarand, Iran
万方数据知识服务平台
应用市场
我的应用
会员HOT
万方期刊
×

点击收藏,不怕下次找不到~

@万方数据
会员HOT

期刊专题

10.1097/JD9.0000000000000303

Evaluation of Serum Vitamin D Concentration and Blood Eosinophil and Basophil Counts in Patients With Vitiligo: A Cross-sectional Study From Rafsanjan and Zarand, Iran

引用
Objective::Vitiligo is a chronic autoimmune depigmenting skin disorder. In this disease, the destruction of functional melanocytes can lead to reduced or absent pigmentation of the skin. Vitamin D deficiency has been reported in some autoimmune diseases. The association of eosinophils and basophils with autoimmune diseases has also been recently examined. The present study was performed to evaluate the serum vitamin D concentration and blood eosinophil and basophil counts in patients with vitiligo.Methods::Data from 30 patients aged 20 to 40 years with vitiligo and 30 healthy people were collected. Blood samples were obtained to evaluate the serum vitamin D concentration, and eosinophil and basophil counts. The serum vitamin D concentration was measured by enzyme-linked immunosorbent assay. Independent t-test was used to compare the quantitative variables between the groups. Results::This descriptive cross-sectional study involved 30 patients with vitiligo. The average serum vitamin D concentration was significantly lower in the case group than in the control group ( P = 0.01). Furthermore, the mean serum vitamin D concentration was significantly lower in women than in men ( P = 0.03). The average eosinophil and basophil counts were not significantly different between the case and control groups. Discussion::The results of this study showed that the serum vitamin D concentration is low in patients with vitiligo. However, whether this reduction is a factor in the promotion of vitiligo or occurs after the onset of vitiligo remains unknown. Further studies on the serum vitamin D concentration in patients with vitiligo are needed to clarity this issue and develop effective treatments.

autoimmunity、pigmentation disorders、vitiligo、1,25-dihydroxyvitamin D3

06

2024-01-30(万方平台首次上网日期,不代表论文的发表时间)

共5页

136-140

相关文献
评论
暂无封面信息
查看本期封面目录

国际皮肤性病学杂志(英文)

2096-5540

32-1763/R

06

2023,06(3)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn